Clinical Chemistry Link to Randox Laboratories Web Site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Correction for Berois et al., Clin Chem 52 (9) 1701-1712.
Clinical Chemistry 52: 2315-2318, 2006; 10.1373/clinchem.2006.081976
This Article
Right arrow Extract Freely available
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
(Clinical Chemistry. 2006;52:2315-2318.)
© 2006 American Association for Clinical Chemistry, Inc.

Correction

Correction


In the article entitled "ppGalNAc-T13: A New Molecular Marker of Bone Marrow Involvement in Neuroblastoma" by N. Berois, E. Blanc, H. Ripoche, X. Mergui, F. Trajtenberg, S. Cantais, M. Barrois, P. Dessen, B. Kågedal, J. Bérnard, E. Osinaga, and G. Raguénez (Clin Chem 2006;52:1701–12; DOI: 10.1373/clinchem.2006.067975), Tables 2 and 3 were printed from scanned copies of the authors’ original tables in which commas had not been changed to decimal points. The tables presented here also have other changes made in accordance with journal style, such as sequential placement of footnotes in Table 2 , reordering of wording in the Table 3 legend, and elimination of certain abbreviations. The oversight occurred in production.


View this table:
[in this window]
[in a new window]

  		Table 2. Differentially expressed genes for primary tumor xenograft (PTX; stage 4 disease) and BM or Myoc metastatic neuroblasts.


View this table:
[in this window]
[in a new window]

  		Table 2A. Continued


View this table:
[in this window]
[in a new window]

  		Table 2B. Continued


View this table:
[in this window]
[in a new window]

  		Table 3. Clinicopathological characteristics of patients and expression of different markers in BM.





This Article
Right arrow Extract Freely available
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS